SCHEMBL7141971

SCHEMBL7141971

COC(Br)C(=O)c1ccccc1.O=C(CBr)c1ccc2ccccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.64
HPGD P15428 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 2/20 0.46
GSK3B P49841 3/20 0.45
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
GABBR2 O75899 1/20 0.39
GABBR1 Q9UBS5 1/20 0.39
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8103349 0.86 GSK3B (0.61) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL29411099 0.80 PTPN1 (1.00) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL220588 0.80 PTPN1 (1.00) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL316378 0.78 TSHR (0.48) ALDH1A1NPC1RAB9ACES2CES1
SCHEMBL11482012 0.73 PTPN1 (0.84) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL11647490 0.73 MEN1 (0.56) PTPN1HPGDKDM4EALDH1A1RAB9A
Naphthalene SCHEMBL28739292 0.72 GSK3B (0.86) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL571370 0.71 GSK3B (0.71) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL31065275 0.71 GSK3B (0.71) PTPN1HPGDSMN1; SMN2KDM4EGSK3B
SCHEMBL28835358 0.70 GSK3B (0.60) PTPN1SMN1; SMN2GSK3BALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0971901-B1 PHTHALAZINONES ALTANA PHARMA AG (DE) 2003-02-26 EP disclosed